Target intelligence / Profile preview

Rho guanine nucleotide exchange factor 35 (ARHGEF35)

Target
ARHGEF35
Molecular classification
Rho guanine nucleotide exchange factor (RhoGEF), Other
01

Overview

Rho guanine nucleotide exchange factor 35 (ARHGEF35) is a member of the RhoGEF family, proteins that activate Rho family small GTPases by facilitating the exchange of GDP for GTP. These proteins regulate actin cytoskeleton remodeling, cell adhesion, and interactions with the extracellular matrix. Although there is little direct experimental evidence specifically characterizing ARHGEF35, it is assumed to influence actin dynamics and cellular adhesiveness, similar to other RhoGEFs. Dysregulation of this class of proteins is known to contribute to processes such as cell migration and tumor metastasis, but there is no evidence that ARHGEF35 is currently considered a direct therapeutic target or is involved in any specific human disease

Other names
ARHGEF35ARHGEF5LCTAGE4FLJ43692Rho guanine nucleotide exchange factor 5-like proteinRho guanine nucleotide exchange factor (GEF) 35
02

Biological functions

Signal transductionRegulation of actin cytoskeletonCell adhesionCell–matrix interactionPotential role in metastasis/cancer cell invasion
03

Disease associations

Cancer (implicated by analogy to other RhoGEFs)Other (no direct evidence about specific diseases for ARHGEF35)

Beyond the preview

Go deeper on Rho guanine nucleotide exchange factor 35 (ARHGEF35).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rho guanine nucleotide exchange factor 35 (ARHGEF35).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call